Matthew Pollman, M.D.
Founder and Chairman, Guided Interventions Inc2.
Matthew Pollman is the Founder and Chairman at Guided Interventions, Inc., a company which is developing a product to help cardiologists better assess the physiological impact of coronary artery blockages and guide interventional decisions.
He is a cardiologist and cardiovascular molecular biologist with more than twenty years of experience leading R&D initiatives in the biotechnology, diagnostics and medical devices health care arenas.
Before coming to Guided Interventions, Dr. Pollman was Founder, President and Chief Scientific Officer for CV Ingenuity, Medical Director for the Research and Development group at Abbott Vascular and Director of New Ventures at Guidant.
has helped to nurture start-up companies and develop novel therapeutic opportunities utilizing emerging device or combination product technologies.
He has also served as a full-time faculty member at Harvard Medical School and Morehouse School of Medicine.
Pollman holds a B.S. degree from Southwestern Adventist University and earned his M.S and M.D. degrees at Loma Linda University.
received internal medicine training at the University of California San Francisco
and cardiology fellowship training at Stanford University and Brigham and Women's Hospital
He serves as an Executive-in-Residence for Cleveland Clinic Innovations and as a member of the Global Cardiovascular Innovation Center's commercialization advisory board.
He is a member of the board of directors for Juventas Therapeutics and Merlot OrthopediX.
has authored numerous peer-reviewed journal articles.